453 related articles for article (PubMed ID: 33786982)
1. Phenotypic heterogeneity, stability and plasticity in tumor-promoting carcinoma-associated fibroblasts.
Mezawa Y; Orimo A
FEBS J; 2022 May; 289(9):2429-2447. PubMed ID: 33786982
[TBL] [Abstract][Full Text] [Related]
2. Crosstalk between cancer-associated fibroblasts and immune cells in the tumor microenvironment: new findings and future perspectives.
Mao X; Xu J; Wang W; Liang C; Hua J; Liu J; Zhang B; Meng Q; Yu X; Shi S
Mol Cancer; 2021 Oct; 20(1):131. PubMed ID: 34635121
[TBL] [Abstract][Full Text] [Related]
3. Emerging Role of Cancer-Associated Fibroblasts in Progression and Treatment of Hepatocellular Carcinoma.
Akkız H
Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36835352
[TBL] [Abstract][Full Text] [Related]
4. Cancer-associated fibroblasts and the tumor microenvironment in non-small cell lung cancer.
Suzuki J; Tsuboi M; Ishii G
Expert Rev Anticancer Ther; 2022 Feb; 22(2):169-182. PubMed ID: 34904919
[TBL] [Abstract][Full Text] [Related]
5. Immune checkpoint inhibitors as mediators for immunosuppression by cancer-associated fibroblasts: A comprehensive review.
Eskandari-Malayeri F; Rezaei M
Front Immunol; 2022; 13():996145. PubMed ID: 36275750
[TBL] [Abstract][Full Text] [Related]
6. Spatial transcriptomics atlas reveals the crosstalk between cancer-associated fibroblasts and tumor microenvironment components in colorectal cancer.
Peng Z; Ye M; Ding H; Feng Z; Hu K
J Transl Med; 2022 Jul; 20(1):302. PubMed ID: 35794563
[TBL] [Abstract][Full Text] [Related]
7. Architecture of Cancer-Associated Fibroblasts in Tumor Microenvironment: Mapping Their Origins, Heterogeneity, and Role in Cancer Therapy Resistance.
Dzobo K; Dandara C
OMICS; 2020 Jun; 24(6):314-339. PubMed ID: 32496970
[TBL] [Abstract][Full Text] [Related]
8. Cancer associated-fibroblast-derived exosomes in cancer progression.
Li C; Teixeira AF; Zhu HJ; Ten Dijke P
Mol Cancer; 2021 Dec; 20(1):154. PubMed ID: 34852849
[TBL] [Abstract][Full Text] [Related]
9. Cancer-associated fibroblasts in intrahepatic cholangiocarcinoma progression and therapeutic resistance.
Ravichandra A; Bhattacharjee S; Affò S
Adv Cancer Res; 2022; 156():201-226. PubMed ID: 35961700
[TBL] [Abstract][Full Text] [Related]
10. Phenotypic and functional heterogeneity of cancer-associated fibroblast within the tumor microenvironment.
Ishii G; Ochiai A; Neri S
Adv Drug Deliv Rev; 2016 Apr; 99(Pt B):186-196. PubMed ID: 26278673
[TBL] [Abstract][Full Text] [Related]
11. Cancer-associated Fibroblasts in Bladder Cancer: Origin, Biology, and Therapeutic Opportunities.
Caramelo B; Zagorac S; Corral S; Marqués M; Real FX
Eur Urol Oncol; 2023 Aug; 6(4):366-375. PubMed ID: 36890105
[TBL] [Abstract][Full Text] [Related]
12. Metabolic reprogramming and crosstalk of cancer-related fibroblasts and immune cells in the tumor microenvironment.
Zhu Y; Li X; Wang L; Hong X; Yang J
Front Endocrinol (Lausanne); 2022; 13():988295. PubMed ID: 36046791
[TBL] [Abstract][Full Text] [Related]
13. Cancer-associated fibroblasts in nonsmall cell lung cancer: From molecular mechanisms to clinical implications.
Wong KY; Cheung AH; Chen B; Chan WN; Yu J; Lo KW; Kang W; To KF
Int J Cancer; 2022 Oct; 151(8):1195-1215. PubMed ID: 35603909
[TBL] [Abstract][Full Text] [Related]
14. Hematopoietic stem cell derived carcinoma-associated fibroblasts: a novel origin.
McDonald LT; LaRue AC
Int J Clin Exp Pathol; 2012; 5(9):863-73. PubMed ID: 23119103
[TBL] [Abstract][Full Text] [Related]
15. Hematopoietic stem cell-derived adipocytes and fibroblasts in the tumor microenvironment.
Xiong Y; McDonald LT; Russell DL; Kelly RR; Wilson KR; Mehrotra M; Soloff AC; LaRue AC
World J Stem Cells; 2015 Mar; 7(2):253-65. PubMed ID: 25815113
[TBL] [Abstract][Full Text] [Related]
16. The cancer-inhibitory effects of proliferating tumor-residing fibroblasts.
Delinassios JG; Hoffman RM
Biochim Biophys Acta Rev Cancer; 2022 Jan; 1877(1):188673. PubMed ID: 34953931
[TBL] [Abstract][Full Text] [Related]
17. Crosstalk and plasticity driving between cancer-associated fibroblasts and tumor microenvironment: significance of breast cancer metastasis.
Zhang W; Wang J; Liu C; Li Y; Sun C; Wu J; Wu Q
J Transl Med; 2023 Nov; 21(1):827. PubMed ID: 37978384
[TBL] [Abstract][Full Text] [Related]
18. Cancer associated fibroblasts: phenotypic and functional heterogeneity.
Patel AK; Singh S
Front Biosci (Landmark Ed); 2020 Mar; 25(5):961-978. PubMed ID: 32114420
[TBL] [Abstract][Full Text] [Related]
19. Cancer-associated fibroblasts: Mediators of head and neck tumor microenvironment remodeling.
Raudenska M; Balvan J; Hanelova K; Bugajova M; Masarik M
Biochim Biophys Acta Rev Cancer; 2023 Sep; 1878(5):188940. PubMed ID: 37331641
[TBL] [Abstract][Full Text] [Related]
20. Influence of Tumor Microenvironment and Fibroblast Population Plasticity on Melanoma Growth, Therapy Resistance and Immunoescape.
Romano V; Belviso I; Venuta A; Ruocco MR; Masone S; Aliotta F; Fiume G; Montagnani S; Avagliano A; Arcucci A
Int J Mol Sci; 2021 May; 22(10):. PubMed ID: 34067929
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
